FIELD: chemistry.
SUBSTANCE: group of inventions relates to organic chemistry and includes a compound of formula (I), its stereoisomers, a method for production thereof and an anthelmintic veterinary composition containing same. In formula (I), R1 is independently selected from the group consisting of hydrogen, C1-6-alkyl, C1-6-alkoxy and halogen, where C1-6-alkyl is optionally substituted with one to three halogens, R7 is independently selected from a group consisting of C1-6-alkyl, C2-6-alkenyl, 5–10-membered heteroaryl containing 1–2 heteroatoms selected from N and O, C1-6-alkoxy, hydroxy, NR8R9, SR10, SOR10, SO2R10, where each C1-6-alkyl and 5–10-membered heteroaryl containing 1–2 heteroatoms selected from N and O is optionally substituted with hydroxy, R8 and R9 are independently selected from the group consisting of hydrogen and C1-6-alkyl, which is optionally substituted with C1-6-alkoxy, hydroxy, NR8''R9'', R10 is C1-6-alkyl, R8", R9" are independently selected from hydrogen and C1-6-alkyl, R13 is hydrogen or C1-3-alkyl, R14 is hydrogen, or R13 and R14 together with the atoms to which they are attached form a non-aromatic ring containing 5 or 6 carbon atoms, where ring containing 5 or 6 carbon atoms is optionally substituted with one or more substitutes selected from C1-3-alkyl or =O, and/or where one of the ring-forming carbon atoms is optionally substituted with -O-, or R13 and R14 together with the atoms to which they are attached form an aromatic ring containing 5 or 6 carbon atoms, where ring containing 5 or 6 carbon atoms is optionally substituted with one C1-3-alkyl substituent, and/or where one or more of the ring-forming carbon atoms are optionally substituted -O-, A1 is N or CR15, where R15 is independently hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy or NR15'R15", where R15' and R15'' independently represent C1-3-alkyl, A2 is N or CR16, where R16 is independently hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy or NR16'R16'', where R16' and R16'' are independently C1-3-alkyl, A3 is CR17, where R17 is hydrogen, A4 is N or CR18, where R18 is independently hydrogen, R19 is C6-10-aryl optionally substituted with one to three halogens, R25 is independently selected from hydrogen and C1-6-alkyl.
EFFECT: compound of formula (I) and its stereoisomers have pronounced anthelmintic activity, particularly with respect to Dirofilaria immitis.
13 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTHELMINTIC COMPOUNDS CONTAINING AZAINDOLE STRUCTURE | 2020 |
|
RU2833563C1 |
NEW AZAQUINOLINE DERIVATIVES | 2018 |
|
RU2773290C2 |
NOVEL ANTHELMINTIC COMPOUNDS | 2019 |
|
RU2828007C2 |
NEW BICYCLIC PYRAZOLE DERIVATIVES | 2018 |
|
RU2781426C2 |
NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | 2017 |
|
RU2772283C2 |
COMPOUNDS USABLE FOR THE TREATMENT OF RESPIRATORY DISEASE IN CATTLE OR PIGS | 2017 |
|
RU2775529C2 |
N-HETEROARYL COMPOUNDS | 2011 |
|
RU2596185C2 |
AZOLINES | 2015 |
|
RU2727307C2 |
COMPOUNDS USED FOR TREATMENT OF PASTEURELLA MULTOCIDA OR MANNHEIMIA HAEMOLYTICA INFECTION | 2017 |
|
RU2781450C2 |
NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
Authors
Dates
2025-01-24—Published
2020-12-17—Filed